UCLA Hematology/Oncology - Ventura

Clinical research site in Ventura, California

Part of UCLA

As of July 2026, 2 paid clinical trials are recruiting at UCLA Hematology/Oncology - Ventura in Ventura, California. Active studies at this site cover conditions such as Cancer of the Prostate, Hormone Sensitive Prostate Cancer and Metastatic Castration Sensitive Prostate Cancer (mCSPC). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at UCLA Hematology/Oncology - Ventura (2)

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

for Metastatic Castration Sensitive Prostate Cancer (mCSPC)

122 locations incl. Huntsville

Sponsor: Pfizer

Sex: Male·Age: 18+

Code: NCT07028853·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

for Urothelial Carcinoma

144 locations incl. Gilbert

Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All·Age: 18+

Code: NCT04879329·Phase 2·Recruiting·Listed May 2021

Apply to this trial

More research sites in Ventura

Explore more

Paid clinical trials in Ventura, CA · California clinical trials